We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Skin Imaging With Technologies in Development

This study has been withdrawn prior to enrollment.
(Not a clinical trial)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00764920
First Posted: October 2, 2008
Last Update Posted: August 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine
  Purpose
The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalities to collect information on normal and lesional skin. The researchers understand that the purpose of this study is not to evaluate any particular treatment and an investigation of a new therapeutic intervention would require an additional protocol. Skin conditions to be studied include vascular lesions, pigmentary disorders, inflammatory conditions and neoplasms.

Condition Intervention
Pigmented Skin Lesion of Uncertain Nature Device: non-invasive imaging modalities for assessment of skin

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Other
Official Title: Non-invasive Imaging Modalities for Assessment of Normal and Lesional Skin

Resource links provided by NLM:


Further study details as provided by Beckman Laser Institute and Medical Center, University of California, Irvine:

Primary Outcome Measures:
  • Collect information on normal and lesional skin [ Time Frame: up to 12 weeks ]
    Develop non-invasive imaging modalities for assessment of skin.


Enrollment: 0
Study Start Date: October 2008
Estimated Study Completion Date: October 2018
Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Skin Imaging
non-invasive imaging modalities for assessment of skin
Device: non-invasive imaging modalities for assessment of skin
skin imaging

Detailed Description:

Normal and lesional skin will be assessed by the following imaging modalities:

  1. Laser Speckle Imaging can provide information about relative blood flow in a tissue. In skin it can be used to determine what areas have more blood flow and whether a particular intervention or treatment affects blood flow.
  2. Optical Coherence Tomography and Optical Doppler Tomography can provide pictures of blood vessels in an area of the body and can also tell how fast blood is flowing in that area.
  3. Photon Migration Spectroscopy can provide information about the amount of blood, oxygen, fat and water is in a tissue.
  4. Multi-Spectral Imaging can provide a 3 dimensional image of structures within the skin.
  5. Multiphoton Microscopy can provide images of structures of the skin.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   7 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Study population will be selected from University of California Irvine Medical Clinic
Criteria

Inclusion Criteria:

  • adult male or female 7 and older; able to carry out study instructions

Exclusion Criteria:

  • Younger than 7 years old
  • pregnant woman
  • breast feeding
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00764920


Locations
United States, California
Beckman Laser Institute Medical clinic
Irvine, California, United States, 92612
Sponsors and Collaborators
University of California, Irvine
Beckman Laser Institute University of California Irvine
Investigators
Principal Investigator: Kristen M Kelly, MD Beckman Laser Institute University of California Irvine
  More Information

Responsible Party: Beckman Laser Institute and Medical Center, Kristen Kelly, M.D.,Professor Departments of Dermatology and Surgery, University of California, Irvine
ClinicalTrials.gov Identifier: NCT00764920     History of Changes
Other Study ID Numbers: NIH/LAMMP-2008-6307
First Submitted: September 30, 2008
First Posted: October 2, 2008
Last Update Posted: August 25, 2017
Last Verified: August 2017

Keywords provided by Beckman Laser Institute and Medical Center, University of California, Irvine:
human skin

Additional relevant MeSH terms:
Pigmentation Disorders
Skin Diseases
Pathologic Processes